SN.L : Summary for SMITH & NEPHEW PLC ORD USD0.20 - Yahoo Finance

U.S. Markets open in 56 mins.

Smith & Nephew plc (SN.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,208.00+7.00 (+0.58%)
As of 1:13PM GMT. Market open.
People also watch
SMIN.LREL.LSHP.LWOS.LRB.L
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1,201.00
Open1,201.00
Bid1,208.00 x 240300
Ask1,209.00 x 53000
Day's Range1,201.00 - 1,213.00
52 Week Range1,064.91 - 1,324.00
Volume549,366
Avg. Volume2,791,309
Market Cap10.56B
Beta0.69
PE Ratio (TTM)13.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.31 (2.11%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Smith & Nephew Plc breached its 50 day moving average in a Bearish Manner : SN-GB : February 28, 2017
    Capital Cube4 hours ago

    Smith & Nephew Plc breached its 50 day moving average in a Bearish Manner : SN-GB : February 28, 2017

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Smith & Nephew Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)

  • PR Newswire6 days ago

    Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure injury technology

    LONDON, Feb. 22, 2017 /PRNewswire/ -- Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today announces it has taken a strategic investment and signed a distribution agreement with Leaf Healthcare, a developer of a unique wireless patient monitoring system for pressure ulcer/injury prevention. This agreement supports Smith & Nephew's strategic priority to innovate for value by delivering solutions that help healthcare professionals better improve the life of their patients. "Smith & Nephew is focused on providing not just products to treat conditions, but also supporting customers through technologies designed to support prevention as well as treatment," said Glenn Warner, President U.S., Smith & Nephew.

  • American City Business Journals14 days ago

    These drug and medical device companies made the most payments to N.Y.C. hospitals

    Medical device company Medtronic Neurovascular made the highest amount of non-research payments out of the more than $127 million in payments received by 25 New York City-area doctors in 2015. Minneapolis-based ...